Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-08-29

Clinical Trial Update: NGAL and Its Association With the No-reflow Phenomenon in ST-elevation Myocardial Infarction

View source ↗

Summary

This document reports a clinical trial update examining whether NGAL levels are associated with the no-reflow phenomenon in patients with ST-elevation myocardia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sheba Medical Center | Conditions: No-Reflow Phenomenon, STEMI - ST Elevation Myocardial Infarction | Status: UNKNOWN